TLR4−/− mice and mice given LPS-RS, a TLR4 antagonist, exhibited decreased systemic IL6 and TNF-α levels after hindlimb ischemia, implicating the role of TLR4 in ischemia-induced systemic inflammatory cytokine production. Here, IL6 is linked to ischemia.